{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:27:27Z","timestamp":1778758047439,"version":"3.51.4"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"State administration of traditional chinese medicine Youth Qihuang Scholars Project in 2020"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"abstract":"<jats:p>\n                    This study aimed to investigate the mechanism of the\n                    <jats:italic toggle=\"yes\">Coptidis Rhizoma<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">Cinnamomi Cortex<\/jats:italic>\n                    (HL-RG) drug pair in the intervention of renal cell carcinoma (RCC) using network pharmacology, molecular docking, and cell experiments. Network pharmacology analysis predicted 42 active components in HL-RG and identified 227 potential targets. Among these, 50 targets were specifically associated with RCC, and 18 were identified as hub genes. Three components (quercetin, oleic acid, tetrandrine) were highlighted as particularly effective. The results of the gene ontology (GO) annotation showed that HL-RG may treat RCC by regulating biological processes such as inflammation, immune response, cell cycle process, and lipid metabolism. Kyoto Gene and Genome Encyclopedia (KEGG) enrichment revealed that the key targets of HL-RG in treating RCC were enriched in the proteoglycans in cancer, and the HIF-1 signaling pathway. Molecular docking results demonstrated that 87% of the interactions exhibited binding energies stronger than \u22125.0 kcal\/mol, indicating favorable binding affinity between the core active components and key targets. Experimental validation using quantitative real-time polymerase chain reaction and Western blot in 786-O cells demonstrated that tetrandrine (TET) and quercetin (QUE) downregulated the mRNA and protein levels of G1\/S-specific cyclin-D1 (CCND1) and Transforming growth factor beta-1 (TGFB1), and upregulated the mRNA levels of Catalase (CAT). Additionally, QUE downregulated the mRNA levels of Receptor tyrosine-protein kinase erbB-2 (ERBB2) and upregulated the mRNA levels of Pro-epidermal growth factor (EGF). Furthermore, oleic acid (OA), TET, and QUE downregulated the protein levels of Matrix metalloproteinase-9 (MMP9). In conclusion, the therapeutic effect of the HL-RG combination against RCC is primarily mediated by its bioactive components, QUE, OA, and TET. These components regulate the HIF-1 signaling pathway, activating genes involved in the cellular response to hypoxia and modulating the expression of proteins that control glucose metabolism, cell proliferation, and angiogenesis.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000043786","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:01:01Z","timestamp":1764169261000},"page":"e43786","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effective components of Coptidis Rhizoma and Cinnamomi Cortex in the treatment of renal cell carcinoma and their mechanism of action"],"prefix":"10.1097","volume":"104","author":[{"given":"Dongmei","family":"Duan","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of NBC Protection for Civilian, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjun","family":"Chen","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2651-6969","authenticated-orcid":false,"given":"Liyuan","family":"Tan","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Geriatric Diseases, The Second Medical Center, Chinese PLA General Hospital, Beijing, China"},{"name":"Shanghai Livzon Pharmaceutical Co., Ltd, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Song","sequence":"additional","affiliation":[{"name":"Beijing Tongrentang Technology Development Co., Ltd, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260514","first-page":"2013","article-title":"Research progress in serum protein markers of renal cell carcinoma.","volume":"44","author":"Fu","year":"2022","journal-title":"Chin J Cell Biol"},{"key":"R2-20260514","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R3-20260514","first-page":"115","article-title":"Cancer statistics in China.","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00001622-200005000-00013","article-title":"Renal cell carcinoma.","volume":"12","author":"Godley","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"R5-20260514","first-page":"1413","article-title":"Professor Zhu Shijie\u2019s experience in treating renal cancer by warming Yang and dispelling accumulation.","volume":"45","author":"Xie","year":"2023","journal-title":"Hebei J TCM"},{"key":"R6-20260514","first-page":"105","article-title":"Wang Mianzhi\u2019s experience in using herb pairs.","volume":"43","author":"Qiu","year":"2002","journal-title":"J Tradit Chin Med"},{"key":"R7-20260514","first-page":"2053","article-title":"Academic experience inheritance of master of traditional Chinese medicine WANG Mianzhi: couplet herbs of traditional Chinese medicine for treatment of severe cases.","volume":"45","author":"Sun","year":"2018","journal-title":"Liaoning J Tradit Chin Med"},{"key":"R8-20260514","first-page":"56","article-title":"Composition analysis, antioxidant and anti-renal-cancer activities of epimedium polysaccharide.","volume":"50","author":"Liu","year":"2023","journal-title":"Guangdong Chem Ind"},{"key":"R9-20260514","first-page":"4","article-title":"Effect and mechanism of Celastrol in the treatment of renal carcinoma based on network pharmacology and experimental verification.","volume":"20","author":"Yan","year":"2023","journal-title":"China Med Herb"},{"key":"R10-20260514","doi-asserted-by":"crossref","first-page":"e33729","DOI":"10.1097\/MD.0000000000033729","article-title":"Network pharmacology and molecular docking to explore the pharmacological mechanism of Yifei Tongluo granules in treating idiopathic pulmonary fibrosis: a review.","volume":"102","author":"Hou","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"R11-20260514","doi-asserted-by":"crossref","first-page":"756550","DOI":"10.3389\/fimmu.2021.756550","article-title":"Bioinformatics and network pharmacology identify the therapeutic role and potential mechanism of melatonin in AD and rosacea.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"R12-20260514","doi-asserted-by":"crossref","first-page":"105454","DOI":"10.1016\/j.compbiomed.2022.105454","article-title":"Mechanisms underlying the therapeutic effects of Qingfeiyin in treating acute lung injury based on GEO datasets, network pharmacology and molecular docking.","volume":"145","author":"Wang","year":"2022","journal-title":"Comput Biol Med"},{"key":"R13-20260514","doi-asserted-by":"crossref","first-page":"168.e1","DOI":"10.1016\/j.urolonc.2015.11.001","article-title":"Characterization of clear cell renal cell carcinoma by gene expression profiling.","volume":"34","author":"Thibodeau","year":"2016","journal-title":"Urol Oncol"},{"key":"R14-20260514","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12931-021-01781-1","article-title":"Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach.","volume":"22","author":"Zhu","year":"2021","journal-title":"Respir Res"},{"key":"R15-20260514","doi-asserted-by":"crossref","first-page":"638366","DOI":"10.3389\/fcell.2021.638366","article-title":"Decoding the mechanism of Huanglian Jiedu decoction in treating pneumonia based on network pharmacology and molecular docking.","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R16-20260514","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/can.2020.0025","article-title":"A network pharmacology approach to identify potential molecular targets for cannabidiol\u2019s anti-inflammatory activity.","volume":"6","author":"Ma","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"R17-20260514","doi-asserted-by":"crossref","first-page":"1037856","DOI":"10.3389\/fphar.2022.1037856","article-title":"Therapeutic targets and pharmacological mechanisms of Coptidis Rhizoma against ulcerative colitis: findings of system pharmacology and bioinformatics analysis.","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R18-20260514","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/07853890.2022.2034931","article-title":"The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking.","volume":"54","author":"Zhu","year":"2022","journal-title":"Ann Med"},{"key":"R19-20260514","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/acs.chemrestox.6b00245","article-title":"Rational selection of the 3D structure of biomacromolecules for molecular docking studies on the mechanism of endocrine disruptor action.","volume":"29","author":"Yang","year":"2016","journal-title":"Chem Res Toxicol"},{"key":"R20-20260514","doi-asserted-by":"crossref","first-page":"113907","DOI":"10.1016\/j.jep.2021.113907","article-title":"Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K\/AKT\/mTOR pathway.","volume":"271","author":"Liu","year":"1139","journal-title":"J Ethnopharmacol"},{"key":"R21-20260514","doi-asserted-by":"crossref","first-page":"149359","DOI":"10.1016\/j.bbrc.2023.149359","article-title":"Bioinformatics analysis and experimental validation reveal the anti-ferroptosis effect of FZD7 in acute kidney injury.","volume":"692","author":"Long","year":"1493","journal-title":"Biochem Biophys Res Commun"},{"key":"R22-20260514","doi-asserted-by":"crossref","first-page":"149244","DOI":"10.1016\/j.bbrc.2023.149244","article-title":"Bioinformatics and experimental studies jointly reveal that Sacubitril Valsartan improves myocardial oxidative stress and inflammation by regulating the MAPK signaling pathway to treat chemotherapy related cardiotoxicity.","volume":"690","author":"Shi","year":"1492","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20260514","doi-asserted-by":"crossref","first-page":"116290","DOI":"10.1016\/j.jep.2023.116290","article-title":"A Plantaginis Semen-Coptidis Rhizoma compound alleviates type 2 diabetic mellitus in mice via modulating AGEs-RAGE pathway.","volume":"312","author":"Liu","year":"1162","journal-title":"J Ethnopharmacol"},{"key":"R24-20260514","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1038\/s41598-022-09559-1","article-title":"Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking.","volume":"12","author":"Yang","year":"2022","journal-title":"Sci Rep"},{"key":"R25-20260514","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1080\/10717544.2021.1977422","article-title":"Rhizoma polygonatiNetwork pharmacology and experimental investigation of extract targeted kinase with herbzyme activity for potent drug delivery.","volume":"28","author":"Xie","year":"2021","journal-title":"Drug Deliv"},{"key":"R26-20260514","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/ptr.7012","article-title":"Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology.","volume":"35","author":"Lin","year":"2021","journal-title":"Phytother Res"},{"key":"R27-20260514","doi-asserted-by":"crossref","first-page":"e0273498","DOI":"10.1371\/journal.pone.0273498","article-title":"Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy.","volume":"17","author":"Fang","year":"2022","journal-title":"PLoS One"},{"key":"R28-20260514","first-page":"131","article-title":"Progress research on clinical application and safety evaluation of the antitumor effect on rhizoma coptidis.","volume":"19","author":"Lu","year":"2017","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"R29-20260514","first-page":"31","article-title":"Study on chemical constituents, antitumor and anti-inflammatory activities of Cinnamomi Ramulus.","volume":"53","author":"Qian","year":"2022","journal-title":"Chin Tradit Herb Drugs"},{"key":"R30-20260514","first-page":"145","article-title":"The latest research on antitumor mechanism of quercetin.","volume":"35","author":"Zhang","year":"2022","journal-title":"West J Tradit Chin Med"},{"key":"R31-20260514","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ptr.7309","article-title":"Quercetin and its derivates as antiviral potentials: a comprehensive review.","volume":"36","author":"Di Petrillo","year":"2022","journal-title":"Phytother Res"},{"key":"R32-20260514","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2174\/1871520619666190705150214","article-title":"Quercetin loaded nanoparticles in targeting cancer: recent development.","volume":"19","author":"Vinayak","year":"2019","journal-title":"Anticancer Agents Med Chem"},{"key":"R33-20260514","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.3390\/ijms20133177","article-title":"The anti-cancer effect of quercetin: molecular implications in cancer metabolism.","volume":"20","author":"Reyes-Farias","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R34-20260514","doi-asserted-by":"crossref","first-page":"113655","DOI":"10.1016\/j.yexcr.2023.113655","article-title":"Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction.","volume":"429","author":"Liu","year":"2023","journal-title":"Exp Cell Res"},{"key":"R35-20260514","doi-asserted-by":"crossref","first-page":"110139","DOI":"10.1016\/j.intimp.2023.110139","article-title":"Tetrandrine alleviates atherosclerosis via inhibition of STING-TBK1 pathway and inflammation in macrophages.","volume":"119","author":"Li","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R36-20260514","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11596-023-2725-6","article-title":"Tetrandrine represses inflammation and attenuates osteoarthritis by selective inhibition of COX-2.","volume":"43","author":"Gao","year":"2023","journal-title":"Curr Med Sci"},{"key":"R37-20260514","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2147\/JIR.S401566","article-title":"FLI1 regulates histamine decarboxylase expression to control inflammation signaling and leukemia progression.","volume":"16","author":"Hu","year":"2023","journal-title":"J Inflamm Res"},{"key":"R38-20260514","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3892\/ol.2023.13811","article-title":"Study on the mechanism of oral administration of tetrandrine during neoadjuvant chemotherapy for colon cancer.","volume":"25","author":"Li","year":"2023","journal-title":"Oncol Lett"},{"key":"R39-20260514","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tox.2019.01.014","article-title":"Hepatic carboxylesterases are differentially regulated in PPAR\u03b1-null mice treated with perfluorooctanoic acid.","volume":"416","author":"Wen","year":"2019","journal-title":"Toxicology"},{"key":"R40-20260514","doi-asserted-by":"crossref","first-page":"108773","DOI":"10.1016\/j.envres.2019.108773","article-title":"Effect of subacute and prenatal DINCH plasticizer exposure on rat dams and male offspring hepatic function: the role of PPAR-\u03b1.","volume":"179","author":"Campioli","year":"2019","journal-title":"Environ Res"},{"key":"R41-20260514","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/jcb.21538","article-title":"Catalase overexpression impairs TNF-alpha induced NF-kappaB activation and sensitizes MCF-7 cells against TNF-alpha.","volume":"103","author":"L\u00fcpertz","year":"2008","journal-title":"J Cell Biochem"},{"key":"R42-20260514","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s11011-019-00481-6","article-title":"Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid \u03b2-induced rat model of Alzheimer\u2019s disease: underlying mechanisms.","volume":"34","author":"Baluchnejadmojarad","year":"2019","journal-title":"Metab Brain Dis"},{"key":"R43-20260514","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1002\/jcb.28261","article-title":"Esculentoside H inhibits colon cancer cell migration and growth through suppression of MMP-9 gene expression via NF-kB signaling pathway.","volume":"120","author":"Ha","year":"2019","journal-title":"J Cell Biochem"},{"key":"R44-20260514","first-page":"19","article-title":"Inhibition of ERBB2 gene on hepatoma HepG2 cell growth and PI3K\/AKT signaling pathway.","volume":"54","author":"Hu","year":"2019","journal-title":"J Zhengzhou Univ Med Sci"},{"key":"R45-20260514","doi-asserted-by":"crossref","first-page":"12375","DOI":"10.3892\/mmr.2021.12375","article-title":"hsa-miR-15a-5p inhibits colon cell carcinoma via targeting CCND1.","volume":"24","author":"Li","year":"2021","journal-title":"Mol Med Rep"},{"key":"R46-20260514","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3233\/BD-220068","article-title":"GLIS2 and CCND1 expression levels in breast cancer patients.","volume":"42","author":"Sadeghi","year":"2023","journal-title":"Breast Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:05:40Z","timestamp":1778756740000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":46,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043786","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2024-09-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}